Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
MTNB Matinas BioPharma
- 0.5680
- -0.0130-2.24%
Close Dec 13 16:00 ET
- 0.5403
- -0.0277-4.88%
Post 20:01 ET
2.89MMarket Cap-0.12P/E (TTM)
0.5701High0.5205Low240.40KVolume0.5700Open0.5810Pre Close129.35KTurnover4.85%Turnover RatioLossP/E (Static)5.09MShares21.500052wk High0.18P/B2.82MFloat Cap0.500052wk Low--Dividend TTM4.96MShs Float197.5000Historical High--Div YieldTTM8.54%Amplitude0.5000Historical Low0.5380Avg Price1Lot Size
Matinas BioPharma News
Matinas BioPharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Highbridge Capital Management, LLC(9.99%)
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Matkovits Theresa
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Hoover Thomas
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Kucinski Keith A
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Chief Technology Officer Liu Hui
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Jabbour Jerome D
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Officer Ferguson James J. III
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Director Ende Eric J
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Director Corzo Kathryn Penkus
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Director WIKLER MATTHEW
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Director CONRAD HERBERT J
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Director Scibetta James S
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities-Director Giordano Natasha
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities
Matinas BioPharma | 4: Statement of changes in beneficial ownership of securities
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.